Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
186 hedge funds and large institutions have $1.05B invested in Natus Medical Inc in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 42 increasing their positions, 72 reducing their positions, and 35 closing their positions.
54% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 35
24% more capital invested
Capital invested by funds: $847M → $1.05B (+$205M)
8% more funds holding
Funds holding: 172 → 186 (+14)
42% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 72
50% less call options, than puts
Call options by funds: $528K | Put options by funds: $1.05M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Melqart Asset Management
London,
United Kingdom
|
+$24.1M |
| 2 |
Morgan Stanley
New York
|
+$22.8M |
| 3 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$19.1M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$16.8M |
| 5 |
Millennium Management
New York
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$30.2M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$23.8M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$16.5M |
| 4 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
-$15.6M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
-$12M |
NTUS Hedge Fund Activity: Q2 2022 in Review
186 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2022, worth a combined $1.05B — up 24% from $847M a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new NTUS positions and 35 closed out — a net gain of 19 holders — while 42 added to existing stakes and 72 trimmed.
The largest buyer was Melqart Asset Management, opening a new position worth an estimated $24.1M. The largest seller was Ameriprise, cutting an estimated $30.2M.
- 186 institutional investors held Natus Medical Inc (NTUS) as of Q2 2022, up from 172 in Q1 2022.
- Funds reported $1.05B of Natus Medical Inc stock for Q2 2022, up 24% quarter-over-quarter.
- 54 funds opened new Natus Medical Inc positions in Q2 2022 and 35 closed out, a net change of +19 holders.
- The largest Natus Medical Inc buyer in Q2 2022 was Melqart Asset Management, an estimated $24.1M added.
- The largest Natus Medical Inc seller in Q2 2022 was Ameriprise, an estimated $30.2M sold.
Based on aggregated 13F filings for Q2 2022.